In our case-control study comprising up to 1424 cases and 1114 healthy controls, we investigated the role of genetic polymorphisms in the regulatory regions of NLRC5, PD-L1 and the previously genotyped regulatory SNPs in the IFNGR genes on the risk of CRC. This evidence concerns the gene CD274 and colorectal carcinoma.